Stephen L. Sabba, Director at LIGAND PHARMACEUTICALS INC (LGND), bought 2,000 shares at $11.69 ($23K) on 2011-11-10, disclosed to the SEC on 2011-11-14.
Open-market purchase of $23k LGND by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.69 | 1,000 | $12K | 50.4% |
| 2 | $11.50 | 1,000 | $12K | 49.6% |
| Total | $11.60 avg | 2,000 | $23K | 100% |
| Filing → |
| LGND | SELL | 2026-03-05 | $410K | — | Filing → |
| LGND | SELL | 2024-03-07 | $281K | — | Filing → |
| LGND | SELL | 2023-05-12 | $988K | — | Filing → |